» Articles » PMID: 35125014

Adiposity Increases Weight-bearing Exercise-induced Dyspnea Despite Favoring Resting Lung Hyperinflation in COPD

Overview
Publisher Sage Publications
Date 2022 Feb 7
PMID 35125014
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Our aim was to study the associations between resting lung hyperinflation, weight-bearing exercise-induced dyspnea and adipose distribution in obese and normal-weight COPD patients.

Methods: We performed a comparison between 80 obese COPD patients (COPD) with 80 age- and FEV matched normal-weight COPD patients (COPD). Dyspnea was assessed by the mMRC scale and the Borg dyspnea score before and after a 6 min walk test. Further characterization included spirometry, body plethysmography and metronome paced tachypnea (MPT) to estimate dynamic hyperinflation. Body composition was assessed with bioelectrical impedance analysis. Associations between dyspnea scores and BMI and body composition groups were studied using logistic regression models.

Results: COPD patients had attenuated increases in TLC, FRC and RV compared to COPD patients ( < 0.01). The groups had comparable 6 min walking distance and ΔFRC upon MPT ( > 0.05). Compared to COPD, COPD patients reported more often a mMRC ≥ 2 (65 vs 46%; = 0.02; OR 3.0, 95% CI 1.4-6.2, < 0.01) and had higher ΔBorg upon 6MWT: 2.0 (SEM 0.20) vs. 1.4 (SEM 0.16), = 0.01; OR for ΔBorg ≥ 2: 2.4, 95% CI 1.1-5.2, = 0.03. Additional logistic regression analyses on the associations between body composition and dyspnea indicated that increased body fat percentage, fat mass index and waist-to-hip ratio were associated with higher ORs for mMRC ≥ 2 and ΔBorg upon 6MWT ≥ 2.

Conclusion: Despite its beneficial effect on resting lung hyperinflation, adiposity is associated with increased weight-bearing exercise-induced dyspnea in COPD.

Citing Articles

Knowledge, attitude, and practice toward interstitial lung disease among patients: a cross-sectional study.

Xu W, Li Q, Mao Y, He Y Front Med (Lausanne). 2024; 11:1397659.

PMID: 38966525 PMC: 11222668. DOI: 10.3389/fmed.2024.1397659.


Exercise ventilation and dyspnea in the obese patient with chronic obstructive pulmonary disease: "how much" versus "how well".

Neder J Chron Respir Dis. 2021; 18:14799731211059172.

PMID: 34823379 PMC: 8649746. DOI: 10.1177/14799731211059172.

References
1.
Cecere L, Littman A, Slatore C, Udris E, Bryson C, Boyko E . Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD. 2011; 8(4):275-84. PMC: 3169653. DOI: 10.3109/15412555.2011.586660. View

2.
Sanchez Castillo S, Smith L, Diaz Suarez A, Lopez Sanchez G . Physical Activity Behaviour in People with COPD Residing in Spain: A Cross-Sectional Analysis. Lung. 2019; 197(6):769-775. DOI: 10.1007/s00408-019-00287-4. View

3.
Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54(7):581-6. PMC: 1745516. DOI: 10.1136/thx.54.7.581. View

4.
ODonnell D, Ciavaglia C, Neder J . When obesity and chronic obstructive pulmonary disease collide. Physiological and clinical consequences. Ann Am Thorac Soc. 2014; 11(4):635-44. DOI: 10.1513/AnnalsATS.201312-438FR. View

5.
Parshall M, Schwartzstein R, Adams L, Banzett R, Manning H, Bourbeau J . An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012; 185(4):435-52. PMC: 5448624. DOI: 10.1164/rccm.201111-2042ST. View